Ketogenic diet for infantile epileptic spasms

Area of Science:

• Neuroscience
• Biochemistry
• Pediatric Neurology

Background:

• Infantile Epileptic Spasms Syndrome (IESS) affects infants, with ~50% unresponsive to first-line therapies like vigabatrin and hormonal treatments.
• Lack of consensus on second-line treatments for IESS necessitates exploring alternative therapeutic strategies.
• The ketogenic diet (KD) is recognized for efficacy in drug-resistant epilepsies and shows potential in IESS cases.

Purpose of the Study:

• To review the current understanding of the ketogenic diet's mechanisms of action in IESS, based on animal models.
• To highlight the role of KD in inducing brain acidosis via altered respiration.
• To explore recent findings on the gut microbiome and tryptophan-serotonin-kynurenine pathway alterations in KD-treated IESS animal models.

Main Methods:

• Review of existing literature and animal model studies on ketogenic diet and IESS.
• Analysis of data related to KD's impact on respiration, brain pH, gut microbiome, and neurotransmitter pathways.
• Synthesis of findings to elucidate KD's therapeutic mechanisms in IESS.

Main Results:

• The ketogenic diet influences respiration, leading to brain acidosis, a potential anticonvulsant mechanism.
• Alterations in the gut microbiome are implicated in the KD's efficacy for IESS.
• The tryptophan-serotonin-kynurenine pathway is affected by KD in IESS models, suggesting neurochemical modulation.

Conclusions:

• Understanding KD mechanisms in IESS provides a foundation for developing novel therapeutics.
• Targeting gut microbiome and neurochemical pathways could offer new treatment avenues for refractory IESS.
• Further research into KD's multifaceted effects may lead to more accessible and effective IESS therapies.